Related Experiment Video
Updated: Jul 9, 2026
09:03
Manufacture and Drug Delivery Applications of Silk Nanoparticles
Published on: October 8, 2016
Characterization of nanoparticles for therapeutics
Jennifer B Hall1, Marina A Dobrovolskaia, Anil K Patri
1SAIC-Frederick Inc., Nanotechnology Characterization Laboratory, Advanced Technology Program, NCI-Frederick, 1050 Boyles St., Bldg. 469, Frederick, MD 21702, USA.
Nanomedicine (London, England)
|December 22, 2007
Summary
Nanomedicines offer advantages but require specialized preclinical development. This study highlights methods for characterizing nanoparticles, assessing their toxicity, and ensuring efficacy for medical applications.
Area of Science:
- Biomedical Engineering
- Materials Science
- Pharmacology
Background:
- Nanotechnology provides significant benefits for drug design, delivery, and diagnostics.
- Nanomedicines, while promising, face substantial preclinical development hurdles.
- The unique properties of nanoparticles necessitate adaptations to standard characterization methods.
Purpose of the Study:
- To outline a rational characterization strategy for nanomedicines.
- To highlight advanced methods for nanoparticle assessment.
- To discuss the evaluation of nanomedicine toxicity and efficacy.
Main Methods:
- Physicochemical characterization of nanoparticle constructs.
- Sterility and pyrogenicity testing.
- Biodistribution (ADME) and toxicity studies (in vitro and in vivo).
Main Results:
- Progress in specialized characterization techniques for nanoparticles is presented.
- Methods indicative of nanoparticle toxicity and efficacy are discussed.
- A comprehensive approach to nanomedicine preclinical development is outlined.
Conclusions:
- Effective preclinical development of nanomedicines relies on tailored characterization strategies.
- Advanced methods are crucial for understanding nanoparticle behavior and safety.
- Addressing characterization challenges is key to realizing the potential of nanomedicines.
